arrow
Back
A

Alexander M.M. Eggermont

European Academy of Cancer Sciences

102H-index
641Paper Count
6.0WCitation Count
Published Papers 275
Publication Date
Developing evidence-based, cost-effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities
err2025-12-15
err0
errOAAI
errUlrik Ringborg; Joachim von Braun; Julio Celis; Anton Berns; Michael Baumann; Tit Albreht; Nancy Abou-Zeid; Vanderlei Bagnato; Christian Brandts; Chien-Jen Chen; Massimiliano di Pietro; Manjit Dosanjh; Thomas Dubois; Alexander Eggermont; Angelika Eggert; Ingemar Ernberg; Sara Faithfull; Johannes Förner; Stefan Fröhling; Manuel Heitor; Leroy Hood; Wei Jiang; Bengt Jönsson; Ravi Kannan; Maria Leptin; Su Li; Peter Lindgren; Douglas Lowy; Jun Ma; Alex Markham; Péter Nagy; Simon Oberst; M. Iqbal Parker; Danielle Rodin; Kevin Ryan; Joachim Schüz; Richard Sullivan; Josep Tabernero; Peter Turkson; Oliver Várhelyi; Harold Varmus; Chijie Wang; Elisabete Weiderpass; Nils Wilking
errShare
errSave
Approaches to overcome the current treatment plateau in immunotherapy
err2025-07-06
err0
PREAI
errAnna Maria Di Giacomo; Renzo Canetta; John Connolly; Rom Leidner; Wei Zheng; Young Kim; Ramy Ibrahim; Michael Lahn; Michael Smith; Alexander Eggermont; Bernard A. Fox; Michele Maio
errShare
errSave
Reduction in surgical interventions in melanoma
err2025-05-01
err0
errOAAI
errAkkooi, Alexander C. J. van; Eggermont, Alexander M. M.
errShare
errSave
Risk stratification using the Merlin Assay (CP-GEP) in an independent cohort of 930 patients with clinical stage I/II melanoma who did not undergo sentinel lymph node biopsy
err2025-05-01
err0
errOAAI
errAmaral, Teresa; Chatziioannou, Eftychia; Nuebling, Alica; Nanz, Lena; Sinnberg, Tobias; Niessner, Heike; Arentsen, Tim; Ruiter, Romy; Dwarkasing, Jvalini; Eggermont, Alexander M.; Leiter, Ulrike; Flatz, Lukas; Forchhammer, Stephan
errShare
errSave
Prognostic value of baseline EORTC QLQ-C30 scores for overall survival across 46 clinical trials covering 17 cancer types: a validation study
err2025-04-01
err0
PREAI
errLim, Luigi; Machingura, Abigirl; Taye, Mekdes; Pe, Madeline; Coens, Corneel; Martinelli, Francesca; Alanya, Ahu; Antunes, Stephanie; Tu, Dongsheng; Basch, Ethan; Ringash, Jolie; Brandberg, Yvonne; Groenvold, Mogens; Eggermont, Alexander; Cardoso, Fatima; Van Meerbeeck, Jan; Koller, Michael; van der Graaf, Winette T. A.; Taphoorn, Martin J. B.; Koekkoek, Johan A. F.; Reijneveld, Jaap C.; Soffietti, Riccardo; Velikova, Galina; Bottomley, Andrew; Flechtner, Henning; Musoro, Jammbe
errShare
errSave
Seven-year analysis of adjuvant pembrolizumab versus placebo in stage III melanoma in the EORTC1325 / KEYNOTE-054 trial
err2024-11-01
err2
PREAI
errEggermont, Alexander M. M.; Kicinski, Michal; Blank, Christian U.; Mandala, Mario; V. Long, Georgina; Atkinson, Victoria; Dalle, Stephane; Haydon, Andrew; Meshcheryakov, Andrey; Khattak, Adnan; Carlino, Matteo S.; Sandhu, Shahneen; Larkin, James; Puig, Susana; Ascierto, Paolo A.; Rutkowski, Piotr; Schadendorf, Dirk; Boers-Sonderen, Marye; Di Giacomo, Anna Maria; van den Eertwegh, Alfonsus J. M.; Grob, Jean-Jacques; Gutzmer, Ralf; Jamal, Rahima; van Akkooi, Alexander C. J.; Lorigan, Paul; Grebennik, Dmitri; Kreplere, Clemens; Marreaud, Sandrine; Suciu, Stefan; Robert, Caroline
errShare
errSave
Efficacy of anti PD-1 therapy in children and adolescent melanoma patients (MELCAYA study)
err2024-11-01
err1
errOAAI
errMandala, Mario; Ferrari, Andrea; Brecht, Ines B.; Suijkerbuijk, Karijn P. M.; Maschke, Linda; Giannarelli, Diana; Indini, Alice; Ubaldi, Martina; Pecci, Giulia; Atkinson, Victoria; Helgadottir, Hildur; Chiaravalli, Stefano; Benannoune, Naima; Robert, Caroline; Teterycz, Pawel; Rutkowski, Piotr; Puig, Susana; Madonna, Gabriele; Kebudi, Rejin; Grynberg, Shirly; Arantes, Lidia M. R. B.; Bien, Ewa; Krawczyk, Malgorzata; Pasquale, Maria Debora De; Dierselhuis, Miranda P.; Massi, Daniela; V. Long, Georgina; Ascierto, Paolo Antonio; Eggermont, Alexander M. M.
errShare
errSave
Pembrolizumab versus placebo after a complete resection of high-risk stage III melanoma: 7-year results of the EORTC 1325-MG/Keynote-054 double-blind phase III trial
err2024-09-01
err0
PREAI
errEggermont, A. M. M.; Kicinski, M.; Blank, C. U.; Mandala, M.; Long, G. V.; Atkinson, V. G.; Dalle, S.; Haydon, A. M.; Meshcheryakov, A.; Khattak, M. A.; Carlino, M. S.; Sandhu, S. K.; Sarda, S. Puig; Ascierto, P. A.; Lorigan, P.; Grebennik, D.; Krepler, C.; Marreaud, S. I.; Suciu, S.; Robert, C.
errShare
errSave
Primary analysis of the EORTC 1208 Minitub trial: Prospective registry of sentinel node (SN) positive melanoma patients with minimal SN tumor burden
err2024-09-01
err0
PREAI
errvan Akkooi, A. C. J.; Massi, D.; Kicinski, M.; Brackley, P.; Gruenhagen, D.; Rastrelli, M.; Signh, M.; Peach, H.; Peric, B.; Caraco, C.; Boecxstaens, V.; Moncrieff, M.; Marreaud, S. I.; Louis, R.; de Schaetzen, G.; Koljenovic, S.; van de Wiel, B.; Mandala, M.; Cook, M.; Eggermont, A. M. M.
errShare
errSave
Technical considerations for isolated limb perfusion: A consensus paper
errEJSO
IF2.9
err2024-06-01
err6
PREAI
errHayes, Andrew J.; Coker, David J.; Been, Lukas; Boecxstaens, Veerle WSM.; Bonvalot, Sylvie; De Cian, Franco; Cruz-Merino, Luis de la; Duarte, Carlos; Eggermont, Alexander; Farricha, Victor; Fiore, Marco; Gruenhagen, Dirk; Gruetzmann, Robert; Honore, Charles; Jakob, Jens; Hocevar, Marko; van Houdt, Winan; Klauzner, Joseph; Kettelhack, Christoph; Marten, Angela; Martinez-Said, Hector; Matter, Maurice; Michot, Audrey; Niethard, Maya; Pennacchioli, Elisabetta; Podleska, Lars E.; Rabago, Gregorio; Rastrelli, Marco; Reijers, Sophie; Ribeiro, Matilde; Schwarzbach, Matthias; Snow, Hayden A.; Spacek, Miroslav; Stoldt, Stephan; Testori, Alessandro; Zoras, Odysseas; Bagge, Roger Olofsson
errShare
errSave
Sentinel lymph node risk prognostication in primary cutaneous melanoma through tissue-based profiling, potentially redefining the need for sentinel lymph node biopsy
err2024-05-01
err1
errOAAI
errKoett, Julian; Zimmermann, Noah; Zell, Tim; Ruenger, Alessandra; Heidrich, Isabel; Geidel, Glenn; Smit, Daniel J.; Hansen, Inga; Abeck, Finn; Schadendorf, Dirk; Eggermont, Alexander; Puig, Susana; Hauschild, Axel; Gebhardt, Christoffer
errShare
errSave
The Virtual Child
err2024-04-04
err1
errOAAI
errGilbertson, Richard J.; Behjati, Sam; Boettcher, Anna-Lisa; Bronner, Marianne E.; Burridge, Matthew; Clausing, Henrick; Clifford, Harry; Danaher, Tracey; Donovan, Laura K.; Drost, Jarno; Eggermont, Alexander M. M.; Emerson, Chris; Flores, Mona G.; Hamerlik, Petra; Jabado, Nada; Jones, Andrew; Kaessmann, Henrick; Kleinman, Claudia L.; Kool, Marcel; Kutscher, Lena M.; Lindberg, Gavin; Linnane, Emily; Marioni, John C.; Maris, John M.; Monje, Michelle; Macaskill, Alexandra; Niederer, Steven; Northcott, Paul A.; Peeters, Elizabeth; Plieger-van Solkema, Willemijn; Preussner, Liane; Rios, Anne C.; Rippe, Karsten; Sandford, Peter; Sgourakis, Nikolaos G.; Shlien, Adam; Smith, Pete; Straathof, Karin; Sullivan, Patrick J.; Suva, Mario L.; Taylor, Michael D.; Thompson, Emma; Vento-Tormo, Roser; Wainwright, Brandon J.; Wechsler-Reya, Robert J.; Westermann, Frank; Winslade, Shannon; Al-Lazikani, Bissan; Pfister, Stefan M.
errShare
errSave
Prognostic and predictive value of non-steroidal anti-inflammatory drugs in the EORTC 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma*
err2024-04-01
err0
PREAI
errKennedy, Oliver John; Glassee, Nina; Kicinski, Michal; Blank, Christian U.; V. Long, Georgina; Atkinson, Victoria G.; Dalle, Stephane; Haydon, Andrew M.; Meshcheryakov, Andrey; Khattak, Adnan; Carlino, Matteo S.; Sandhu, Shahneen; Larkin, James; Puig, Susana; Ascierto, Paolo A.; Rutkowski, Piotr; Schadendorf, Dirk; Boers-Sonderen, Marye; Giacomo, Anna Maria Di; Eertwegh, Alfonsus J. M. van den; Grob, Jean -Jacques; Gutzmer, Ralf; Jamal, Rahima; Akkooi, Alexander C. J. van; Gandini, Sara; Buhrer, Emanuel; Suciu, Stefan; Robert, Caroline; Eggermont, Alexander M. M.; Mandala, Mario; Lorigan, Paul; Valpione, Sara
errShare
errSave
Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Outcomes in histopathologic subgroups from the randomized, double-blind, phase 3 KEYNOTE-716 trial
err2024-03-13
err1
errOAAI
errSchadendorf, Dirk; Luke, Jason John; Ascierto, Paolo A.; Long, Georgina, V; Rutkowski, Piotr; Khattak, Adnan; Del Vecchio, Michele; de la Cruz-Merino, Luis; Mackiewicz, Jacek; Sileni, Vanna Chiarion; Kirkwood, John M.; Robert, Caroline; Grob, Jean-Jacques; Dummer, Reinhard; Carlino, Matteo S.; Zhao, Yujie; Kalabis, Mizuho; Krepler, Clemens; Eggermont, Alexander; Scolyer, Richard A.
errShare
errSave
Clinical and translational attributes of immune-related adverse events
err2024-02-15
err20
PREAI
errSuijkerbuijk, Karijn P. M.; van Eijs, Mick J. M.; van Wijk, Femke; Eggermont, Alexander M. M.
errShare
errSave
The future of targeting cytotoxic T-lymphocyte-associated protein-4: Is there a role?
err2024-02-01
err2
errOAAI
errDi Giacomo, Anna Maria; Lahn, Michael; Eggermont, Alexander M. M.; Fox, Bernard; Ibrahim, Ramy; Sharma, Padmanee; Allison, James P.; Maio, Michele
errShare
errSave
Strategies to decrease inequalities in cancer therapeutics, care and preventionProceedings on a conference organized by the Pontifical Academy of Sciences and the European Academy of Cancer Sciences, Vatican City, February 23-24, 2023
err2024-01-22
err11
errOAAI
errRingborg, Ulrik; von Braun, Joachim; Celis, Julio; Baumann, Michael; Berns, Anton; Eggermont, Alexander; Heard, Edith; Heitor, Manuel; Chandy, Mammen; Chen, Chien-Jen; Costa, Alberto; De Lorenzo, Francesco; De Robertis, Edward M.; Dubee, Frederick Charles; Ernberg, Ingemar; Gabriel, Mariya; Helland, Aslaug; Henrique, Rui; Joensson, Bengt; Kallioniemi, Olli; Korbel, Jan; Krause, Mechthild; Lowy, Douglas R.; Michielin, Olivier; Nagy, Peter; Oberst, Simon; Paglia, Vincenzo; Parker, M. Iqbal; Ryan, Kevin; Sawyers, Charles L.; Schuz, Joachim; Silkaitis, Katherine; Solary, Eric; Thomas, David; Turkson, Peter; Weiderpass, Elisabete; Yang, Huanming
errShare
errSave
European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment-Update 2023
err2023-11-01
err23
errOAAI
errStratigos, Alexander J.; Garbe, Claus; Dessinioti, Clio; Lebbe, Celeste; van Akkooi, Alexander; Bataille, Veronique; Bastholt, Lars; Dreno, Brigitte; Dummer, Reinhard; Fargnoli, Maria Concetta; Forsea, Ana Maria; Harwood, Catherine A.; Hauschild, Axel; Hoeller, Christoph; Kandolf-Sekulovic, Lidija; Kaufmann, Roland; Kelleners-Smeets, Nicole W. J.; Lallas, Aimilios; Leiter, Ulrike; Malvehy, Josep; del Marmol, Veronique; Moreno-Ramirez, David; Pellacani, Giovanni; Peris, Ketty; Saiag, Philippe; Tagliaferri, Luca; Trakatelli, Myrto; Ioannides, Dimitrios; Vieira, Ricardo; Zalaudek, Iris; Arenberger, Petr; Eggermont, Alexander M. M.; Roecken, Martin; Grob, Jean-Jacques; EADO; EDF; ESTRO; UEMS; EADV; EORTC
errShare
errSave
European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention-Update 2023
err2023-11-01
err19
errOAAI
errStratigos, Alexander J.; Garbe, Claus; Dessinioti, Clio; Lebbe, Celeste; van Akkooi, Alexander; Bataille, Veronique; Bastholt, Lars; Dreno, Brigitte; Dummer, Reinhard; Fargnoli, Maria Concetta; Forsea, Ana Maria; Harwood, Catherine A.; Hauschild, Axel; Hoeller, Christoph; Kandolf-Sekulovic, Lidija; Kaufmann, Roland; Kelleners-Smeets, Nicole Wj; Lallas, Aimilios; Leiter, Ulrike; Malvehy, Josep; Del Marmol, Veronique; Moreno-Ramirez, David; Pellacani, Giovanni; Peris, Ketty; Saiag, Philippe; Tagliaferri, Luca; Trakatelli, Myrto; Ioannides, Dimitrios; Vieira, Ricardo; Zalaudek, Iris; Arenberger, Petr; Eggermont, Alexander M. M.; Rocken, Martin; Grob, Jean-Jacques; Lorigan, Paul
errShare
errSave